In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  etoposide phosphate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, NCI-2009-00306, COG-AALL0433, CDR0000495359, U10CA098543, NCT00381680

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and under at the time of definitive surgery
Sponsor: NCI, Other
Protocol IDs: ACNS0333, NCI-2009-00337, CDR0000592812, COG-ACNS0333, U10CA098543, NCT00653068

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CPMC-IRB-7866, NCI-G97-1327, NCT00003064

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 07053, P30CA033572, CHNMC-07053, CA180 121, CDR0000617760, NCT00788125

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CWRU4196, P30CA043703, BMS-CRWU-4196, NCI-G00-1854, NCT00006260

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under at original diagnosis
Sponsor: NCI, Other
Protocol IDs: ANBL00P1, COG-ANBL00P1, CDR0000068681, NCT00017368

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000276590, U10CA021115, E5501, ECOG-5501, NCT00057837

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000466167, CALGB-50403, NCT00310037

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: NCI-2009-00323, U10CA098543, CDR0000594224, COG-AAML07P1, AAML07P1, NCT00666588

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000597130, P30CA022453, WSU-2007-127, GENZ-WSU-2007-127, 2007-127, NCT00691015

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: 18 to 50
Sponsor: NCI
Protocol IDs: OSU-08066, OSU 08066, 2008C0112, DFCI-06254, NCT01005758

12.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 1 to 31
Sponsor: NCI
Protocol IDs: NCI-2011-01908, CDR0000638413, AALL07P1, U10CA098543, COG-AALL07P1, NCT00873093

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01917, ECOG-E1508, CDR0000640898, E1508, U10CA021115, U10CA180820, NCT00887159

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 to 75
Sponsor: NCI, Other
Protocol IDs: OHSU-5729-2, 5729-2, ONC-99055-L, 935, OHSU-ONC-99055-L, CASE-CCF-3669, NCT00074178

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2310.00, NCI-2009-01562, 7157, P30CA015704, NCT01097057

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI, Other
Protocol IDs: 698, U01HL069294, U01HL069294-06, BMT CTN 0803, NCT01141712

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: CDR0000066029, CHMC-6006, FHCRC-1244.00, NCI-G98-1373, NCT00003194

18.

Phase: Phase I
Type: Supportive care, Treatment
Status: Temporarily closed
Age: 1 to 18
Sponsor: NCI, Other
Protocol IDs: OHSU-2050, OHSU-8522, OHSU-SOL-04085-L, OHSU-IRB-2050, NCT00238173

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: NCI-2011-02554, CDR0000689575, OSU-10093, 8803, U01CA076576, P30CA016058, NCT01249430

20.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000458052, UCSF-03301, UCSF-H9414-23160-02A, NCT00416819
New Search